Home > Publications
Publications

Publications

Published papers

Conference Presentations

PUBLISHED PAPERS

CHIPS published papers

Collins IJ, Foster C, Tostevin A, Tookey PA, Riordan A, Dunn D, et al. Clinical status of adolescents with perinatal HIV at transfer to adult care in the UK/Ireland. linical Infectious Diseases, in press.

Kenny K, Doerholt K, Gibb DM, Judd A on behalf of the CHIPS Steering Committee. Who gets severe gynaecomastia among HIV-infected children in the UK and Ireland? 2016. Pediatric Infectious Disease Journal. doi:10.1097/INF.0000000000001424.

Turkova, A, Chappell E, Judd A et al., Prevalence, incidence, and associated risk factors of tuberculosis in children with HIV living in the UK and Ireland (CHIPS): a cohort study. Lancet HIV, 2015 2(12): p. e530-e539.

Childs T, Shingadia D, Goodall R, Doerholt K, Lyall H, Duong T, Judd A, Gibb DM, Collins IJ.  Outcomes after viral load rebound on first-line antiretroviral therapy in HIV-infected children in the UK/ Ireland: an observational cohort study.  Lancet HIV, 2015. 2(4): p. e151-e158.

Payne H, Judd A¸ Donegan K, Okike IO, Ladhani S, Doerholt K, Heath PT.  Incidence of pneumococcal and varicella disease in HIV-infected children and adolescents in the UK and Ireland, 1996-2011: two potentially vaccine-preventable infections.  Pediatric Infectious Disease Journal 2015; 34(2): 149-154. 

Duong T, Judd A, Collins J, Doerholt K, Lyall H, Foster C, Butler K, Tookey P, Shingadia D, Menson E, Dunn DT, Gibb DM.  Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland.  AIDS 2014; 28(16): 2395-2405.

Gkentzi D, Tebruegge M, Tudor-Williams G, et al. Incidence, Spectrum and Outcome of Immune Reconstitution Syndrome in HIV-Infected Children Following Initiation of Antiretroviral Therapy. The Pediatric Infectious Disease Journal, March 2014.

Fish R, Judd A, Jungmann E, O’Leary C, Foster C. Mortality amongst HIV-infected young people following transition to adult care: an HIV Young Persons Network (HYPNet) audit. HIV Medicine. HIV Med. 2014 Apr;15(4):239-44.

Donegan K, Doerholt K, Judd A, Lyall H, Menson E, Butler K, Tookey P, Riordan A, Shingadia D, Tudor-Williams G, Gibb DM, Walker AS, on behalf of the Collaborative HIV Paediatric Study (CHIPS).  Lopinavir dosing in HIV-infected children in the UK and Ireland.  PIDJ 2013; 32: 45-50.  (PubMed reference)

Kenny J, Musiime V, Judd A, Gibb D.  Recent advances in pharmacovigilance of antiretroviral therapy in HIV-infected and exposed children.  Current Opinion in HIV AIDS 2012; 7(4): 305-16.  (PubMed reference)

Donegan KL, Walker AS, Dunn D, Judd A, Pillay D, Menson E, Lyall H, Tudor-Williams G, Gibb DM on behalf of the Collaborative HIV Paediatric Study and the UK HIV Drug Resistance Database. The prevelence of Darunavir associated mutations in HIV-1 infected children in the UK. Antiviral Therapy.  Antiviral Therapy 2012;17:599-603.  (PubMed reference)

Judd A, Boyd K, Stohr W, Dunn D, Butler K, Lyall EGH, Sharland M, Shingadia D, Riordan A, Gibb DM. Effect of Tenofovir Disoproxil Fumarate (TDF) on risk of renal abnormality in HIV-1 infected children on antiretroviral therapy: a nested case-control study. AIDS 2010; 24(4): 525-534. (PubMed reference)

Judd A, Ferrand RA, Jungmann E, Foster C, Masters J, Rice B, Lyall H, Tookey PA, Prime K. Vertically acquired HIV diagnosed in adolescence and early adulthood in the UK and Ireland: findings from national surveillance. HIV Medicine 2009; 10: 253-256. (Download Paper)

Foster C, Judd A, Tookey P, Tudor-Williams G, Dunn D, Shingadia D, Butler K, Sharland M, Gibb D, Lyall H. Young people in the UK and Ireland with perinatally acquired HIV: the paediatric legacy for adult services. AIDS Patient Care and STDs 2009; 23(3): 159-166. (PubMed reference)

Kekitiinwa A, Lee KJ, Walker AS, Maganda A, Doerholt K, Kitaka S, Asiimwe A, Judd A, Musoke P, Gibb DM. Differences in factors associated with initial growth, CD4 and viral load response to ART in Ugandan and UK/Irish HIV-infected children. JAIDS 2008; 49(4): 384-392. (PubMed reference)

Riordan A, Judd A, Boyd K, Cliff D, Doerholt K, Lyall H, Menson E, Butler K, Gibb D. Tenofovir use in human immunodeficiency virus-1 infected children in the United Kingdom and Ireland. Paediatric Infectious Diseases Journal 2009; 28(3): 204-209.(PubMed reference) 

Chakraborty R, Smith CJ, Dunn D, Green H, Duong T, Doerholt K, Riordan A, Lyall H, Tookey P, Butler K, Sabin C, Gibb DM, Pillay D. HIV-1 drug resistance in HIV-1 infected children in the United Kingdom from 1998 to 2004. Paediatric Infectious Disease Journal 2008; 27(5): 457-459. This is a non-final version of an article published in final form in Paediatric Infectious Disease Journal 2008; 27(5): 457-459. www.pidj.com (Download Paper)

Lee, KJ, Shingadia D, Pillay D, Walker AS, Riordan A, Menson E, Duong T, Tudor-Williams G, Gibb DM on behalf of the Collaborative HIV Paediatric Study (CHIPS) Steering Committee. Transient viral load increases in HIV-infected children in the UK and Ireland: what do they mean? Antiviral Therapy 2007; 12(6): 949-956. [This is the author's version of a work accepted for publication by International Medical Press. Changes resulting from the publishing process, including peer review, editing and formatting, might not be reflected in this document. A definitive version was published in Antiviral Therapy [Vol 12, Issue 6] © 2007 International Medical Press] (Download pre-publication paper)

Judd A, Doerholt K, Tookey PA, Sharland M, Riordan A, Menson E, Novelli V, Lyall EG, Masters J, Tudor-Williams G, Duong T, Gibb DM. Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care. Clinical Infectious Diseases 2007;45(7):918-924. © 2007 by the Infectious Diseases Society of America. (Download paper)

Menson EN, Walker AS, Sharland M, Wells C, Tudor-Williams G, Riordan FAI, Lyall EGH, Gibb DM for the Collaborative HIV Paediatric Study Steering Committee. Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study. British Medical Journal 2006; 332:1183-1187. (Download paper)

Doerholt K, Duong T, Tookey P, Butler K, Lyall H, Sharland M, Novelli V, Riordan A, Dunn D, Walker AS, Gibb DM. Outcomes for human immunodeficiency virus-1-infected infants in the United Kingdom and Republic of Ireland in the era of effective antiretroviral therapy. Pediatric Infectious Disease Journal 2006; 25: 420-426. (PubMed reference)

Walker AS, Doerholt K, Sharland M, Gibb DM, for the Collaborative HIV Paediatric Study (CHIPS) Steering Committee. Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study. AIDS 2004; 18(14): 1915-1924. (PubMed reference)

Gibb DM, Duong T, Leclezio VA, Walker AS, Verweel G, Dunn DT, for the Collaborative HIV Paediatric Study (CHIPS) Steering Committee and Sophia Children’s Hospital, Rotterdam, The Netherlands. Immunological changes during unplanned treatment interruptions of highly active antiretroviral therapy in children with human immunodeficiency virus type 1 infection. Paediatric Infectious Disease Journal 2004; 23(5): 446-450. (PubMed reference)

Gibb DM, Duong T, Tookey PA, Sharland M, Tudor-Williams G, Novelli V, Butler K, Riordan A, Farrelly L, Masters J, Peckham CS, Dunn DT, on behalf of the National Study of HIV in Pregnancy and Childhood (NSHPC) and the Collaborative HIV Paediatric Study (CHIPS). Decline in mortality, AIDS and hospital admissions in perinatally HIV-1 infected children in the UK and Ireland. BMJ 2003; 327: 1019. (Download paper)

CHIPS published papers resulting from collaborations with other studies

The European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) in EuroCoord. Safety of zidovudine/lamivudine scored tablets in children with HIV infection in Europe and Thailand. European Journal of Clinical Pharmacology, in-press.

Ngo-Giang-Huong, N., Wittkop, L., Judd, A., Reiss, P., Goetghebuer, T., Duiculescu, D. et al. on behalf of the EuroCoord-CHAIN-EPPICC joint project study group. Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project. BMC Infect Dis, 2016, 16 (1), 654. doi:10.1186/s12879-016-1968-2

The Pediatric AIDS-defining Cancer Project Working Group for IeDEA Southern Africa TApHOD and COHERE in EuroCoord. Kaposi Sarcoma risk in HIV-infected children and adolescents on combination antiretroviral therapy from sub-Saharan Africa, Europe and Asia. Clinical Infectious Diseases, 2016 Nov 1;63(9):1245-1253. Epub 2016 Aug 30.

Schomaker M, Leroy V, Wolfs T, Technau KG, Renner L, Judd A, et al. on behalf of the IeDEA West and Southern Africa regional collaborations and COHERE in EuroCoord. Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents – a multiregion analysis from Southern Africa, West Africa, and Europe. International Journal of Epidemiology, 2016. doi:10.1093/ije/dyw097

The Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Higher rates of triple class virologic failure in perinatally HIV-infected teenagers compared to heterosexually infected young adults in Europe. HIV Medicine, 2016 doi:10.1111/hiv.12411

Judd A, Le Prevost M, Melvin D, Arenas-Pinto A, Parrott F, Winston A, et al. Cognitive function in young people with and without perinatal HIV in the AALPHI cohort in England: the role of non-HIV related factors. Clinical Infectious Diseases, 2016, 63 (10), 1380-1387. doi:10.1093/cid/ciw56

Judd A, Collins IJ, Lodi S, Olson A, Pantazis N, Gibb DM for EPPICC. Children and young people with perinatal HIV in Europe: epidemiological situation in 2014 and implications for the future. Eurosurveillance, 21 (10). doi:10.2807/1560-7917.ES.2016.21.10.30162.

The European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) in EuroCoord. Safety of darunavir and atazanavir in HIV-infected children in Europe and Thailand. Antiviral Therapy, 2016. 21 (4), 353-358. doi:10.3851/IMP3008.

Collins IJ, Judd A, Gibb DM.  Immediate antiretroviral therapy in young HIV-infected children: benefits and risks.  Current Opinion in HIV/AIDS 2014; 9(1): 87-94.

Engsig FN, Zangerle R, Katsarou O, et al. for the Antiretroviral Therapy Cohort Collaboration (ART-CC) and the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Long-term Mortality in HIV-Positive Individuals Virally Suppressed for >3 Years With Incomplete CD4 Recovery. Clin Infect Dis. 2014 Feb 25.

Judd A, Duong T, Galli L et al. Post-licensing safety of fosamprenavir in HIV-infected children in Europe. Pharmacoepidemiology and Drug Safety 2014; 23(3): 321-325.

European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord.  Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants.  AIDS 2013 Mar 27;27(6):991-1000. doi: 10.1097/QAD.0b013e32835cffb1. (PubMed reference)

The European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC).  Early antiretroviral therapy in HIV-1 infected infants in Europe, 1996-2008: treatment response and duration of first-line regimens.  AIDS 2011; 25: 2279-2287

The Pursuing Later Treatment Options II (PLATO II) project team. Risk of triple-class virological failure in children with HIV: a retrospective cohort study. Lancet 2011; 377(9777): 1580-7 (PubMed reference)

Wittkop L, Gunthard HF, de Wolf F, Dunn D, Cozzi-Lepri A, de Luca A et al. Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroChoord-CHAIN joint project): a European multicohort study. Lancet Infectious Diseases 2011; 11(5): 363-71. (PubMed reference)

Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE), Mocroft A, Reiss P, Kirk O, Mussini C, Girardi E, Morlat P, Stephen C, De Wit S, Doerholt K, Ghosn J, Bucher HC, Lundgren JD, Chene G, Miro JM, Furrer H. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL? Clin Infect Dis. 2010 Sep 1;51(5):611-9. (Download paper)

Goetghebuer T, Haelterman E, Le Chenadec J, Dollfus C, Gibb DM, Judd A, Green H, Galli L, Faye A, Tomas Ramos J, Giaquinto C, Warszawski J, Levy J for the European Infant Collaboration group. Effect of early antiretroviral therapy on the risk of AIDS/death in HIV infected infants: the European Infant Collaborative Study. AIDS 2009; 23: 597-604. (PubMed reference)

Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study group. Response to combination antiretroviral therapy: variation by age. AIDS 2008; 22: 1463-1473. (Download paper)

Dunn DT, Gibb DM, Duong T for the HIV Paediatric Prognostic Markers Collaborative Study (HPPMCS). Predictive value of absolute CD4 cell count for disease progression in untreated HIV-1 infected children. AIDS 2006; 20:1289-1294. (PubMed reference)

Dunn DT, Gibb DM, Duong T et al. HIV Paediatric Prognostic Markers Collaborative Study. Use of total lymphocyte count for informing when to start antiretroviral therapy in HIV-infected children: a meta-analysis of longitudinal data. Lancet 2005;366:1868-1874. (Download pre-publication paper)  (PubMed reference)

Charakida M, Donald AE, Green H, Storry C, Clapson M, Caslake M, Dunn DT, Halcox JP, Gibb DM, Klein NJ. Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy. Circulation 2005; 112: 103-109. (PubMed reference)

Dunn DT, on behalf of the HIV Paediatric Prognostic Markers Collaborative Study. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet 2003; 362: 1605-1611. (Download pre-publication paper)  (PubMed reference)

CONFERENCE PRESENTATIONS

Conference presentations 2016

Slogrove A, Judd A, Leroy A, Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration. The epidemiology of perinatally HIV-infected adolescents: a CIPHER cohort collaboration global analysis. AIDS 2016, and HIV Pediatrics Workshop 2016, Durban, South Africa

Goodall RL, Chiappini E, Gibb DM, Klimkait T, Ngo-Giang-Huong N, Thorne C, Turkova A, Judd A, European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC). Virological response to first-line ART in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC). AIDS 2016, and HIV Pediatrics Workshop 2016, Durban, South Africa

Judd A, Parrott F, Melvin D, Foster C, Le Prevost M, Evangeli M, Winston A, Arenas-Pinto A, Sturgeon K, Rowson K, Gibb DM. Does neurocognitive function and/or anxiety/depression predict adherence to antiviral therapy among perinatally HIV-infected adolescents in England? AIDS 2016, and HIV Pediatrics Workshop 2016, Durban, South Africa

Le Prevost M, Sturgeon K, Foster C, Parrott F, Jungmann E, Rowson K, Gibb DM, Judd A, Adolescents and Adults Living with Perinatal HIV (AALPHI) Steering Committee. Similar levels of sexual risk behaviour among perinatally HIV-infected and HIV-affected adolescents, and the general population, in England. AIDS 2016, and HIV Pediatrics Workshop 2016, Durban, South Africa

Judd A, Chappell E, Doerholt K, Galli L, Giaquinto C, Gibb DM, Goetghebuer T, Le Coeur S, Noguera Julian A, Turkova A, Goodall R, European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC). Long-term trends in mortality and AIDS-defining events among perinatally HIV-infected children across Europe and Thailand. AIDS 2016, and HIV Pediatrics Workshop 2016, Durban, South Africa

Collins IJ, Chappell E, Ene L, Jourdain G, Riordan A, Scherpbier HJ, Warszawski J, Giaquinto C, Gibb DM, on behalf of the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) in EuroCoord. Poor immune response despite virologically suppressive antiretroviral therapy (ART) in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) in EuroCoord. AIDS 2016, and HIV Pediatrics Workshop 2016, Durban, South Africa

Collins IJ, Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Cohort Collaboration Duration of First-line Team. Switching to second-line antiretroviral therapy (ART) in HIV-infected children: a CIPHER cohort collaboration global analysis. AIDS 2016, and HIV Pediatrics Workshop 2016, Durban, South Africa

Conference presentations 2015

Goodall RL, Collins IJ, Childs T, Foster C, Ene L, Smit C, Kahlert C, Judd A, Gibb DM, on behalf of the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC).  Durability of first-line antiretroviral therapy (ART) in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC).  8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Vancouver 2015 (poster TUPEB304).

Le Prevost M, Melvin D, Nunn A, Arenas-Pinto A, Evangeli M, Foster C, Winston A, Gibb DM, Judd A.  Anxiety and depression in young people with perinatal HIV and their HIV-negative siblings.  7th International Workshop on HIV Pediatrics, Vancouver 2015 (oral).

Le Prevost M, Judd A.  Life after CHIPS: CHIPS and AALPHI update.  9th Annual Conference of the Children’s HIV Association (CHIVA), Leicester 2015 (oral).

Judd A, Nunn A, Melvin D, Foster C, Winston A, Le Prevost M, Sturgeon K, Gibb DM, Arenas-Pinto A.  Neurocognitive function in perinatally HIV-infected young people and HIV-negative siblings in England.  9th Annual Conference of the Children’s HIV Association (CHIVA), Leicester 2015 (oral).

Hawkins A, Evangeli M, Sturgeon K, Le Prevost M, Judd A.  Predictors of within-indivudual episodic antiretroviral adherence in young people living with perinatally acquired HIV.  AIDS Impact 2015 Conference, Amsterdam (oral).

Bailey H on behalf of the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Steering Committee.  Safety of zidovudine/lamivudine scored tablets in children with HIV infection in Europe and Thailand.  33rd Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), 2015 (poster).

Judd A, Nunn A, Melvin D, Foster C, Winston A, Le Prevost M, Sturgeon K, Gibb D, Arenas Pinto A on behalf of the Adolescents and Adults Living with Perinatal HIV (AALPHI) Steering Committee.  Neurocognitive function in perinatally HIV-infected young people and HIV-negative siblings in England.  21st Annual Conference of the British HIV Association, Brighton 2015 (oral).

Judd A, Collins IJ, Le Prevost M, Tookey PA, Gibb DM.  Kids to adults: tracking perinatally infected youth as they transition to adult care - the UK experience.  21st Annual Conference of the British HIV Association, Brighton 2015 (oral).

Hussain N, Lewis J, Childs T, Judd A, Klein N, Fidler K.  To investigate the number of UK paediatric HIV patients with persistently low CD4 counts despite antiretroviral therapy.  21st Annual Conference of the British HIV Association, Brighton 2015 (poster).

Patel A, Judd A, Foster C, Welch S, Menson E, Lim E, Klein N, Fidler K.  To determine the prevalence of HIV seroreversion across 6 collaborating paediatric HIV centres in the UK.  21st Annual Conference of the British HIV Association, Brighton 2015 (oral).

Herbert S, Barbour A, Judd A, Jungmann E, Foster C on behalf of the HIV Young People’s Network (HYPNET).  Malignancy in HIV positive young people.  21st Annual Conference of the British HIV Association, Brighton 2015 (poster).

A Judd. How EPPICC is addressing adolescent transition. 1st CIPHER Adolescent Transition Workshop, 28 March 2015, Catania, Italy (oral presentation)

Nunn A, Arenas-Pinto A, Melvin D, Foster C, Winston A, Le Prevost M, Gibb D, Judd A.  Neurocognitive function in perinatally HIV-infected young people and HIV-negative siblings in England.  19th International Workshop on HIV Observational Databases, Catania, Sicily 2015 (poster).

Bailey H on behalf of the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) in EuroCoord.  Safety of atazanavir and darunavir in patients in paediatric cohorts in Europe and Thailand: a model for ART pharmacovigilance.  19th International Workshop on HIV Observational Databases, Catania, Sicily 2015 (poster) 

Collins IJ, Childs T, Goodall R, Foster C, Ene L, Smit C, Kahlert C, Judd A, Gibb DM on behalf of the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) in EuroCoord.  Durability of first-line antiretroviral therapy (ART) in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC).  19th International Workshop on HIV Observational Databases, Catania, Sicily 2015 (poster).

Panayidou K, Judd A, the IeDEA and COHERE collaborations,  Immunodeficiency at the Start of ART in Children: A Global View Klea, Ali Judd, the IeDEA and COHERE collaborations.  Conference on Retroviruses and Opportunistic Infections 2015, Seattle, USA, 2015 (poster).

Conference presentations 2014

Judd A, Collins J, Lodi S, Olson A, Pantazis N, Gibb DM.  Moving on up: tracking young people with perinatal HIV as they transition to adult care in Europe.  18th International Workshop on HIV Observational Databases, Sitges, Spain, 2014 (oral).  Abstract number 22.

Judd A, Childs T, Collins IJ, Dodonov K, Galli L, Goetghebuer T, Königs C, Noguera-Julian A, Rojo Conejo P, Naver L, Tookey P, Giaquinto C, Gibb DM. Double dosing of ritonavir in twice-daily darunavir-containing regimens: an example of a lack of appropriate formulations in paediatrics. 18th International Workshop on HIV Observational Databases, Sitges, Spain, 2014 (poster).  Abstract number 86.

Collins IJ, Turkova A, Judd A, Welch S, Foster C, Shingadia D, Doeholt K,  Riodan A, Klein K, Shackley F,  Gibb DM on Behalf of the Collaborative HIV Paediatric Study (CHIPS). Tuberculosis (TB) co-infection in HIV-infected children in the UK & Ireland.  18th International Workshop on HIV Observational Databases, Sitges, Spain, 2014 (poster).  Abstract number 90.

Collins IJ, Judd A,  Tookey PA, Foster C, Doerholt K, Lyall H, Butler K, Gibb DM. Improving clinical status of perinatally HIV-infected patients at transfer to adult care over time. 18th International Workshop on HIV Observational Databases, Sitges, Spain, 2014 (poster).  Abstract number 103.

Turkova A, Collins IJ, Judd A, Welch S, Foster C, Shingadia D, Doeholt K, Riodan A, Klein K, Shackley F, Gibb DM on Behalf of the Collaborative HIV Paediatric Study (CHIPS). Tuberculosis (TB) co-infection in HIV-infected children in the UK & Ireland. 18th International Workshop on HIV Observational Databases, Sitges, Spain, 2014 ( Abstract number 90); and 32nd European Society of Paediatric Infectious Diseases, Dublin, Ireland, 2014 (Short oral presentation ESPID-0462).

Collins IJ, Judd A, Tookey PA, Foster C, Doerholt K, Lyall H, Butler K, Gibb DM. Improving clinical status of perinatally HIV-infected patients at transfer to adult care over time. 18th International Workshop on HIV Observational Databases, Sitges, Spain, 2014 (Abstract number 103); and 32nd European Society of Paediatric Infectious Diseases, Dublin, Ireland, 2014 ( Short oral presentation ESPID-0824).

Judd A, Collins J, Lodi S, Olson A, Pantazis N, Gibb DM. Moving on up: tracking young people with perinatal HIV as they transition to adult care in Europe. 18th International Workshop on HIV Observational Databases, Sitges, Spain, 2014. Abstract number 22.

Judd A, Childs T, Collins IJ, Dodonov K, Galli L, Goetghebuer T, Königs C, Noguera-Julian A, Rojo Conejo P, Naver L, Tookey P, Giaquinto C, Gibb DM. Double dosing of ritonavir in twice-daily darunavir-containing regimens: an example of a lack of appropriate formulations in paediatrics. 18th International Workshop on HIV Observational Databases, Sitges, Spain, 2014. Abstract number 86.

Conference presentations 2013

Duong T, Judd A, Doerholt K, Lyall H, Menson E, Foster C et al. Long-term virological outcomes in HIV-infected children on ART in UK/Ireland. 17th International Workshop on HIV Observational Databases, Cavtat, 2013, and 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Kuala Lumpur, 2013 (oral presentation MOAB0105).

Judd A et al. Sex, drugs and mental health: Characteristics of perinatally HIV-infected young people recruited into the new Adolescents and Adults Living with Perinatal HIV (AALPHI) cohort. 17th International Workshop on HIV Observational Databases, Cavtat, 2013, and 5th International Workshop on HIV Pediatrics, Kuala Lumpur, 2013.

Rojo Conejo P on behalf of the PLATO II project team of COHERE. Higher rates of triple class virologic failure in perinatally HIV-infected teenagers compared to heterosexually infected young adults in the PLATO II study. 17th International Workshop on HIV Observational Databases, Cavtat, 2013, and 5th International Workshop on HIV Pediatrics, Kuala Lumpur, 2013.

Conference presentations 2012

Doerholt K, Judd A, Bleier J, Foster C, Menson E, Sharland M et al.  Atazanavir (ATV) use and dosing in HIV-1-infected children in the UK and Ireland.  30th Annual Meeting of the European Society for Paediatric Infectious Diseases, Thessaloniki, 2012 (oral abstract number A-435-0012-01125).

Judd A, Duong T, Ene L, Galli L, Goetghebuer T, Noguera-Julian A, et al. Safety of fosamprenavir and darunavir in HIV-1 infected children in the European Union: ongoing post-marketing surveillance studies. 30th Annual Meeting of the European Society for Paediatric Infectious Diseases, Thessaloniki, 2012 (poster number A-435-0012-00415).

Fish R, Judd A, Jungmann E, Foster C.  Mortality amongst HIV-infected young people following transition to adult care: an HIV Young Persons Network (HYPNet) audit.  18th Annual Conference of the British HIV Association, Birmingham, 2012 (oral abstract number O6); and 6th Annual Conference of the Children’s HIV Association (CHIVA), Birmingham, 2012.

Judd A and Kenny J.  PENTA trials and UK research update.  6th Annual Conference of the Children’s HIV Association (CHIVA), Birmingham, 2012

Conference presentations 2011

Judd A, O’Leary C, Tookey PA, Foster C, Tudor-Williams G, Prime K, Butler K, Menson E, Masters J, Riordan A, Gibb DM.  Coming of age: young people in the UK and Ireland with perinatally acquired HIV infection.  15th International Workshop on HIV Observational Databases, Prague. (Poster)

Judd A on behalf of the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC).  Use and safety of fosamprenavir in HIV-infected children in the European Union: an ongoing post-marketing surveillance study.  15th International Workshop on HIV Observational Databases, Prague. (Poster)

Conference presentations 2010

Payne H, Donegan K, Okike I, Gibb DM, Doerholt K, Heath PT. Prevalence of vaccine-preventable infections among HIV-infected children in the UK and Ireland, 1996-2008. 28th Annual Meeting of the European Society for Paediatic Infectious Diseases, Nice 2010. (Poster) (Download Presentation)

Boyd K, Walker AS, Dunn D, Judd A, Pillay D, Menson E, Tudor-Williams G, Gibb DM. The Prevalence of Darunavir Associated Mutations in PI-naive and PI-experienced HIV-1 Infected Children in the UK. 17th Conference on Retroviruses and Opportunistic infections, San Francisco 2010. (Poster) (Download Presentation)

Conference presentations 2009

Judd A, Boyd K, Stöhr W, Dunn DT, Butler K, Riordan A, Gibb D. Effect of tenofovir disoproxil fumarate (TDF) on risk of renal impairment in HIV-1 infected children on antiretroviral therapy: nested case-control study. 16th Conference on Retroviruses and Opportunistic infections, Montreal 2009. (Poster) (Download Presentation)

Conference presentations 2008

Walker AS, Boyd KL, Doerholt K, Lyall EGH, Menson E, Butler K, Tookey PA, Riordan A, Shingardia D, Judd A, Tudor-Williams G, Gibb DM. To overdose or underdose? The question of Kaletra in the UK/Irish Collaborative HIV Paediatric Study (CHIPS). Ninth International Congress on Drug Therapy in HIV Infection. Glasgow, UK 2008. (Oral) (Download Presentation)

Boyd K on behalf of the Collaborative HIV Paediatric Study (CHIPS). Children and resistance to HIV: CHIPS data. 2nd Annual CHIVA Conference, Liverpool 2008. (Oral) (Download Presentation)

Kekitiinwa A, Lee K, Walker AS, Maganda A, Doerholt K, Lyall H, Butler K, Asiimwe A, Kline M, Gibb D. Initial growth, CD4 and viral load responses to HAART in Ugandan compared to UK/Irish HIV-infected children. 15th Conference on Retroviruses and Opportunstic Infections, Boston 2008. (Poster) (Download Presentation)

Conference presentations 2007

Kekitiinwa A on behalf of the Mulago Cohort Team and the CHIPS Steering Committee. Growth, CD4 and viral load responses to HAART in UK/ Irish and Ugandan HIV-infected children. INTEREST Conference, Uganda 2007.

Cliff D on behalf of CHIPS. Tenofovir use in CHIPS: audit report. British HIV Association Autumn Conference, London 2007 (Oral).

Doerholt K on behalf of CHIPS NSHPC HYPNET CHIC. Adolescent in CHIPS/linking to CHIC: Young persons (YP) leaving CHIPS are lost to follow up - what to do next? British HIV Association Autumn Conference, London 2007 (Oral). (Download presentation)

Doerholt K, Judd A, Tookey P, Sharland M, Riordan A, Menson E, Novelli V, Lyall H, Masters J, Tudor-Williams G, Duong T, Gibb DM. Morbidity, mortality and response to treatment in HIV-infected children in the UK and Ireland 1996-2006: a prospective cohort study. Royal College of Paediatrics and Child Health 11th Spring Meeting, York 2007. (Download presentation)

Foster C, Judd A, Doerholt K, Lyall H, Gibb DM, Tookey P, Dunn T. Young people with perinatally acquired HIV: a Transitioning UK cohort. British Association for Sexual Health and HIV Spring Meeting, Blackpool 2007 (Oral). (Download presentation)

Sabin C and the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study. Response to combination ART: variation by age. Abstract 528. 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles 2007 (Poster). (Download Presentation)

Conference presentations 2006

Judd A, Lee KJ, Duong T, Walker AS, Butler K, Donaghy S, Lyall H, Masters J, Menson E, Novelli V, Peckham C, Riordan A, Sharland M, Tookey P, Tudor-Williams G, Gibb DM. Exposure and response to highly active antiretroviral therapy (HAART) in ART naive children in the UK and Ireland.  XVI International AIDS Conference, Toronto 2006 (Poster; abstract number THPE0106). (Download presentation).

Judd A and Doerholt K on behalf of the Collaborative HIV Paediatric Study (CHIPS) Steering Committee and the National Study of HIV in Pregnancy & Childhood (NSHPC). Characteristics and responses to ART in the CHIPS cohort, 1996-2006. British HIV Association Autumn Conference, London 2006 (Oral). (Download presentation)

Judd A, Duong T, Walker AS, Tookey PA, Sharland M, Riordan A, Lyall H, Masters J, Menson E, Tudor-Williams G, Butler K, Donaghy S, Novelli V, Peckham C, Gibb DM for the Collaborative HIV Paediatric Study and the National Study of HIV in Pregnancy and Childhood. Older and wiser: continued improvements in clinical outcome and highly active antiretroviral therapy (HAART) response in HIV-infected children in the UK and Ireland, 1996-2005. 12th Annual Conference of the British HIV Association, Brighton 2006 (Oral) (Download presentation); Royal College of Paediatrics and Child Health 10th Spring Meeting, York 2006 (Poster). (Download presentation)

Judd A, Duong T, Walker AS, Tookey P, Gibb DM on behalf of the National Study of HIV in Pregnancy and Childhood and the Collaborative HIV Paediatric Study Steering Committee. Trends in morbidity, mortality, and exposure and response to highly active antiretroviral therapy (HAART), in HIV-infected children in the UK and Ireland, 1996-2004. 10th International Workshop on HIV Observational Databases, Madrid 2006 (Poster).

Lee KJ, Lyall H, Walker AS, Sharland M, Judd A and Gibb DM. Wide disparity in switch to second-line therapy in HIV infected children in CHIPS. Eighth International Congress on Drug Therapy in HIV infection, Glasgow 2006 (Oral Paper PL 2.4). (Download presentation)

Lee KJ on behalf of the Collaborative HIV Paediatric Study (CHIPS) Steering Committee. Switch to second-line therapy in the CHIPS cohort. British HIV Association Autumn Conference, London 2006 (Oral). (Download presentation)

Shingadia D, Lee KJ, Pillay D, Walker AS, Tudor-Williams G, Judd A and Gibb DM. Viral load blip in HIV infected children from the CHIPS cohort: what do they mean? Eighth International Congress on Drug Therapy in HIV infection, Glasgow 2006 (Poster; abstract number P359). (Download presentation)

Conference presentations 2005

Menson EN, Walker S, Doerholt K, Duong T, Wells C, Sharland M, Gibb DM on behalf of the Collaborative HIV Paediatric Study. Extent of underdosage of antiretroviral therapy in HIV-infected children. Royal College of Paediatrics and Child Health 9th Spring Meeting, York 2005 (Oral plenary).

Conference presentations 2004

Doerholt K, Walker S, Sharland M, Riordan A, Novelli V, Tookey P, Cole T, Gibb DM. Long-term growth in previously untreated HIV infected children starting Highly Active Antiretroviral Therapy (HAART) in the Collaborative HIV Paediatric Study (CHIPS) in UK and Ireland. XV International AIDS Conference, Bangkok 2004 (Poster; abstract number TuPeB4424).

Doerholt K, Duong T, Sharland M, Tookey P, Butler K, Lyall H, Dunn D, Gibb DM. Poor virological response to HAART among infants in the Collaborative HIV Paediatric Study (CHIPS) in the UK and Ireland. XV International AIDS Conference, Bangkok 2004 (Oral; abstract number TuOrB1188).

Doerholt K, Duong T, Gibb DM on behalf of the CHIPS Steering Committee and the NSHPC. What happens to infants in the era of HAART in the UK and Ireland? 8th International Workshop on HIV Observational Databases, Montreaux 2004 (Closed meeting).

Foster CJ, Lyall EGH, Doerholt K, Duong T, Tookey PA, Sharland M, Tudor-Williams G, Novelli V, Butler K, Riordan A, Gibb DM on behalf of the Collaborative HIV Paediatric Study (CHIPS). HIV infected adolescents: an evolving UK cohort. British HIV Association 10th Anniversary Conference, Cardiff 2004 (Oral). (Download presentation)

Gibb DM, Dunn DT, Duong T, Galli L, Giaquinto C, Hughes M, Mofenson L, Moye J, Newell ML, Palumbo P, Rudin C, Shearer W. Predictive value of total lymphocyte count (TLC) for disease progression in untreated HIV-infected children in Europe and USA. XV International AIDS Conference, Bangkok 2004 (Oral; abstract number TuOrB1189).

Gibb D, Walker S, Doerholt K on behalf of the CHIPS Steering Committee. Variation in the effective dosage of antiretoviral drugs in children. 8th International Workshop on HIV Observational Databases, Montreux 2004 (Closed meeting).

Conference presentations 2003

Doerholt K, Duong T, Sharland M, Tookey P, Masters J, Gibb DM on behalf of CHIPS and NSHPC. Changes in vertically acquired paediatric HIV in UK and Ireland over calendar time: The Collaborative HIV Paediatric Study (CHIPS) and the National Study of HIV in Pregnancy and Childhood (NSHPC). Royal College of Paediatrics and Child Health 7th Spring Meeting, 2003 (Oral; abstract number G165).

Gibb DM, Walker AS on behalf of the Collaborative HIV Paediatric Study Group. Variation in the effect of HAART on short-term CD4 percentage and plasma HIV-1 RNA response according to age in children. 7th International Workshop on HIV Observational Databases, Fiuggi, Italy 2003 (Oral; closed meeting).

Conference presentations 2002

Duong T, on behalf of the HIV Paediatric Prognostic Markers Collaborative Study. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. XIV International AIDS Conference, Barcelona, 2002 (Poster; abstract number TuPec4849).

Duong T, McGee L, Sharland M, Tudor-Williams G, Novelli V, Butler K, Finn A, Tookey P, Peckham C, Dunn D, Gibb DM on behalf of CHIPS. Effects of antiretroviral therapy (ART) on morbidity and mortality of UK and Irish HIV infected children. Royal College of Paediatrics and Child Health 6th Spring Meeting 2002 (Poster; abstract number G210).

Leclezio V, Duong T, McGee L, Martinez-Alier N, Gibb D M, Verweel G. Treatment interruptions of HAART in paediatric HIV: effect on CD4 count. XIV International AIDS Conference, Barcelona 2002 (Poster; abstract number TuPeB4630).

Leclezio V, Duong T, McGee L, Martinez-Alier N, Gibb DM, Verweel G, on behalf of the Collaborative HIV Paediatric Study (CHIPS) Steering Committee. Treatment interruptions of HAART in paediatric HIV: effect on CD4 count. Royal College of Paediatrics and Child Health 6th Spring Meeting 2002 (Poster; abstract number G198).

Sharland M, Duong T, McGee L, Tudor-Williams G, Novelli V, Butler K, Finn A, Tookey P, Peckham C, Dunn D, Gibb D on behalf of the Collaborative HIV Paediatric Study (CHIPS). Effects of antiretroviral therapy (ART) on morbidity and mortality of UK and Irish HIV infected children. European Society for Pediatric Infectious Diseases 20th Annual Meeting, Vilnius, Lithuania 2002.

Walker AS, Gibb DM, McGee L, Dunn D, Tudor-Williams G, Sharland M, Butler K, Novelli V on behalf of the Collaborative HIV Paediatric Study (CHIPS). CD4 and HIV-1 RNA response following HAART in ART-naïve children. XIV International AIDS Conference, Barcelona 2002 (Poster; abstract number TuPeB4631).